Improvement effect on the depth-dose distribution by CSF drainage and air infusion of a tumour-removed cavity in boron neutron capture therapy for malignant brain tumours

被引:11
作者
Sakurai, Y
Ono, K
Miyatake, S
Maruhashi, A
机构
[1] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan
[2] Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka 5698686, Japan
关键词
D O I
10.1088/0031-9155/51/5/009
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Boron neutron capture therapy (BNCT) without craniotomy for malignant brain tumours was started using an epi-thermal neutron beam at the Kyoto University Reactor in June 2002. We have tried some techniques to overcome the treatable-depth limit in BNCT. One of the effective techniques is void formation utilizing a tumour-removed cavity. The tumorous part is removed by craniotomy about I week before a BNCT treatment in our protocol. Just before the BNCT irradiation, the cerebro-spinal fluid (CSF) in the tumour-removed cavity is drained out, air is infused to the cavity and then the void is made. This void improves the neutron penetration, and the thermal neutron flux at depth increases. The phantom experiments and survey simulations modelling the CSF drainage and air infusion of the tumour-removed cavity were performed for the size and shape of the void. The advantage of the CSF drainage and air infusion is confirmed for the improvement in the depth-dose distribution. From the parametric surveys, it was confirmed that the cavity volume had good correlation with the improvement effect, and the larger effect was expected as the cavity volume was larger.
引用
收藏
页码:1173 / 1183
页数:11
相关论文
共 15 条
[1]  
[Anonymous], 1986, BORON NEUTRON CAPTUR
[2]  
[Anonymous], 2000, MCNP GEN MONTE CARLO, DOI DOI 10.1016/J.CCLET.2011.04.015
[3]   The early successful treatment of glioblastoma patients with modified boron neutron capture therapy - Report of two cases [J].
Kawabata, S ;
Miyatake, SI ;
Kajimoto, Y ;
Kuroda, Y ;
Kuroiwa, T ;
Imahori, Y ;
Kirihata, M ;
Sakurai, Y ;
Kobayashi, T ;
Ono, K .
JOURNAL OF NEURO-ONCOLOGY, 2003, 65 (02) :159-165
[4]  
Locher GL, 1936, AM J ROENTGENOL RADI, V36, P1
[5]  
Miyatake S, 2002, RESEARCH AND DEVELOPMENT IN NEUTRON CAPTURE THERAPY, P1129
[6]   IMPLANTABLE DEVICES FOR CHRONIC ACCESS AND DRUG DELIVERY TO THE CENTRAL NERVOUS-SYSTEM [J].
OMMAYA, AK .
CANCER DRUG DELIVERY, 1984, 1 (02) :169-179
[7]   The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice [J].
Ono, K ;
Masunaga, S ;
Suzuki, M ;
Kinashi, Y ;
Takagaki, M ;
Akaboshi, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02) :431-436
[8]  
ONO K, 2000, 9 INT S NEUTR CAPT T, P197
[9]   Characteristics of the KUR Heavy Water Neutron Irradiation Facility as a neutron irradiation field with variable energy spectra [J].
Sakurai, Y ;
Kobayashi, T .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2000, 453 (03) :569-596
[10]   Studies on depth-dose-distribution controls by deuteration and void formation in boron neutron capture therapy [J].
Sakurai, Y .
PHYSICS IN MEDICINE AND BIOLOGY, 2004, 49 (15) :3367-3378